17 June, 2022 Central Drugs Standard Control Organization (CDSCO), the central drug regulatory agency of Government of India has issued a new draft gazette notification to notify Schedule H2 drugs and amendment in Rule 96 of Drugs and Cosmetics…
17 June, 2022 Central Drugs Standard Control Organization (CDSCO), the central drug regulatory agency of Government of India has issued a new gazette notification and waives off the requirement of Transmissible Spongiform Encephalopathies (TSEs) or Bovine Spongiform Encephalopathy (BSE) Certification…
April 30, 2022 Central Drugs Standard Control Organization (CDSCO) under the aegis of Ministry of Health and Family Welfare, Government of India has been taking many steps to control the menace of unapproved and irrational Fixed Dose Combinations (FDCs).…
April 26, 2022 Central Drugs Standard Control Organization (CDSCO), the Drug Regulatory Agency of Government of India granted restricted emergency use authorization (EUA) to Bharat Biotech's Covaxin as a COVID-19 vaccine to vaccinate children between the age of 6-12…
Central Drugs Standard Control Organization, Government of India has recently published their updated list of banned drugs in India. The said list of drugs are prohibited for manufacture/ import and sale in India. The Government of India has issued various…
Recent Post
- CDSCO Issues Public Notice on Disposal of Long-Pending SUGAM Applications
- India Bans High-Dose Nimesulide: What You Need to Know
- Compounding of Offences under the Drugs and Cosmetics Act, 1940: What Stakeholders Need to Know
- 🚨 CDSCO Directive on Immediate Inspections as per Revised Schedule M – Is Your Facility Ready?
- CDSCO Issues Regulatory Clarification on Combi-Pack Approvals: Key Insights for Injectable Manufacturers
